BioSpace News Archive

Teijin Limited announced today that it has signed a research and development agreement with the Japan Agency for Medical Research and Development (AMED) to form an industry-government-academia partnership that will explore preventive and therapeutic drugs for frail elderly people as designated under AMED’s Cyclic Innovation for Clinical Empowerment program(CiCLE) in October 2018.

Expedeon AG today announced that CEO Dr Heikki Lanckriet will deliver a presentation on 15 May 2019 at the German Spring Conference in Frankfurt.

InflaRx today announced the treatment of the first patient in IXchange, a Phase II study with IFX-1 in patients with ANCA-associated vasculitis (AAV) (NCT03895801).

Record Sales of $4.25 Million, Sales Growth of 42%, and Material Net Earnings

Conference call and webcast (in English) today, May 14, 2019 at 3:00 pm CET / 9:00 am EST

Data Safety Monitoring Board (DSMB) recommends the continuation of the RESOLVE-IT clinical trial without any modifications, based on the pre-planned review of safety data

Clinical Ink is pleased to announce that Jonathan Andrus, Chief Business Officer at Clinical Ink, will receive the 2019 Excellence in Service Award from the Drug Information Association’s (DIA) Americas Regional Advisory Council.

Soligenix, Inc. announced its recent accomplishments and financial results for the quarter ended March 31, 2019.

DCprime today announced presentations of additional preclinical data sets for its lead program, DCP-001, at the 7th CCBIO Annual Symposium and the 2019 CIMT Annual Meeting.

TARA Biosystems, Inc. (TARA) today announced that the United States Patent and Trademark Office (USPTO) has issued US Patent 10,254,274 covering methods, compositions and devices for making and using three-dimensional biological tissues that mimic native physiology.